Antidiabetic agents

   
   

Compounds of formula I: ##STR1## wherein X, Y, B, E, J, K, L, Z, and R.sub.9 -R.sub.12 have any of the meanings described herein, their pharmaceutically acceptable salts, lower blood glucose levels and are useful for treating diseases in mammals such as Non-Insulin Dependent Diabetes Mellitus. Also disclosed are pharmaceutical compositions, processes for preparing compounds of formula (I) and intermediates useful for preparing compounds of formula I.

Residui della formula I: ## del ## STR1 in cui X, Y, B, E, J, K, L, Z e R.sub.9 - R.sub.12 hanno c'è ne dei significati descritti qui, dei loro sali farmaceuticamente accettabili, più bassi livelli del glucosio di anima e sono utili per trattare le malattie in mammiferi quale il diabete dipendente Mellitus dell'Non-Insulina. Inoltre sono rilevate le composizioni farmaceutiche, procedimenti per preparare i residui della formula (i) e degli intermediari utili per la preparazione dei residui della formula I.

 
Web www.patentalert.com

< 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds

< Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

> Substituted phenyl derivatives, their preparation and use

> Composition and method for the encapsulation of water-soluble molecules into nanoparticles

~ 00102